Skip to main content
Premium Trial:

Request an Annual Quote

Research and Markets RNAi -- Technologies, Markets, and Companies Report

Premium

Research and Markets recently released its latest RNAi report.

The report, entitled RNAi — Technologies, Markets, and Companies, estimates the market for RNAi reagents to be about $300 million, a figure predicted to grow to $400 million next year and $850 million by 2010.

The report also includes profiles of 75 companies using the techno-logy, as well as their collaborations.

Chapters of the report focus on such topics as alternative RNA splicing, antisense oligonucleotides, ribozymes, locked nucleic acids, RNAi mechanisms, peptide nucleic acids, and historical landmarks in the development of RNAi.

Details about obtaining the report can be found at http://www.researchandmarkets.com/reports/42874/.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.